🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Glucagon-like peptide-1 receptor agonists (GLP-1RA) are powerful second-lin...
Status
Unknown
Location
Servizio di Diabetologia UOC Medicina Generale
Start Date
2018-12-19
Trial ID
NCT03959865
BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Status
Completed
Location
Unit of Endocrinology and Metabolic Diseases
Start Date
2019-11-27
Trial ID
NCT04196231
Treatments Being Tested
Impact of combined Lantus (insulin glargine) and Lyxumia(lixisenatide) on i...
Status
Completed
Location
St. Josef-Hospital, University Hospital, Ruhr
Start Date
2013-12
Trial ID
NCT01910194
Treatments Being Tested
Primary Objective: * to assess the relative bioavailability of a single do...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2010-06
Trial ID
NCT01146678
Treatments Being Tested
Primary Objective: * To demonstrate the superiority of Soliqua 100/33 vers...
Status
Terminated
Location
Investigational Site Number 8400072
Start Date
2018-02-20
Trial ID
NCT03434119
Treatments Being Tested
This was a parallel-group treatment, Phase 3, randomized, 2-arm study that ...
Status
Completed
Location
Investigational Site Number : 1560008
Start Date
2022-07-07
Trial ID
NCT05413369
Treatments Being Tested
Primary Objective: To compare the insulin glargine/lixisenatide fixed rati...
Status
Completed
Location
Investigational Site Number 840027
Start Date
2014-02
Trial ID
NCT02058147
Primary Objective: To demonstrate significant reduction in postprandial pl...
Status
Completed
Location
Investigational Site Number 392-107
Start Date
2014-08
Trial ID
NCT02200991
Treatments Being Tested
Glucocorticoids are commonly used in the treatment of autoimmune, inflammat...
Status
Enrolling By Invitation
Location
Warsaw Medical University
Start Date
2025-07-10
Trial ID
NCT07117240
Treatments Being Tested
The study aims to examine the effectiveness of the short acting GLP-1 analo...
Status
Terminated
Location
Bildirici Diabetes Center, Laniado Hospital
Start Date
2016-07-12
Trial ID
NCT02767596
Treatments Being Tested